PI3K is required for both basal and LPA-induced DNA synthesis in oral carcinoma cells.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Oral Pathology & Medicine

• Publication date

  2016-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/jop.12384PMID 26602326
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck.

  2015cited by this paper
• Lysophosphatidic acid receptors in cancer pathobiology.

  2014cited by this paper
• PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting

  2014cited by this paper
• 516: Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells

  2014cited by this paper
• Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells

  2014cited by this paper
• Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers.

  2013influential reference
• A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins

  2013cited by this paper
• The involvement of the docking protein Gab1 in mitogenic signalling induced by EGF and HGF in rat hepatocytes.

  2013cited by this paper
• Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literature.

  2012cited by this paper
• Controlling cancer through the autotaxin-lysophosphatidic acid receptor axis.

  2012cited by this paper
• Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma

  2012cited by this paper
• Migration induced by epidermal and hepatocyte growth factors in oral squamous carcinoma cells in vitro: role of MEK/ERK, p38 and PI-3 kinase/Akt.

  2012cited by this paper
• Quantitative determination of lysophosphatidic acids (LPAs) in human saliva and gingival crevicular fluid (GCF) by LC-MS/MS.

  2011cited by this paper
• Lysophosphatidic acid 5 receptor induces activation of Na(+)/H(+) exchanger 3 via apical epidermal growth factor receptor in intestinal epithelial cells.

  2011cited by this paper
• The molecular biology of head and neck cancer

  2011cited by this paper
• EGF receptor activation by GPCRs: an universal pathway reveals different versions.

  2011cited by this paper
• Autotaxin and LPA receptor signaling in cancer

  2011cited by this paper
• Mechanisms underlying resistance to cetuximab in the HNSCC cell line: role of AKT inhibition in bypassing this resistance.

  2010cited by this paper
• Mechanisms and functions of p38 MAPK signalling.

  2010cited by this paper
• Differential requirement of the epidermal growth factor receptor for G protein-mediated activation of transcription factors by lysophosphatidic acid

  2010cited by this paper
• LPA receptors: subtypes and biological actions.

  2010cited by this paper
• Molecular targeted therapies in all histologies of head and neck cancers: an update

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• Non-Edg family lysophosphatidic acid (LPA) receptors.

  2009cited by this paper
• Identification of Biomarkers in Human Head and Neck Tumor Cell Lines That Predict For In Vitro Sensitivity to Gefitinib

  2009cited by this paper
• Lysophosphatidic acid promoting corneal epithelial wound healing by transactivation of epidermal growth factor receptor.

  2007cited by this paper
• Signal Strength Dictates Phosphoinositide 3-Kinase Contribution to Ras/Extracellular Signal-Regulated Kinase 1 and 2 Activation via Differential Gab1/Shp2 Recruitment: Consequences for Resistance to Epidermal Growth Factor Receptor Inhibition

  2007cited by this paper
• Scaffolding Protein Grb2-associated Binder 1 Sustains Epidermal Growth Factor-induced Mitogenic and Survival Signaling by Multiple Positive Feedback Loops*

  2006cited by this paper
• Lysophosphatidic acid-induced effects in human colon carcinoma DLD1 cells are partially dependent on transactivation of epidermal growth factor receptor.

  2006cited by this paper
• Lysophosphatidic acid transactivates both c-Met and epidermal growth factor receptor, and induces cyclooxygenase-2 expression in human colon cancer LoVo cells.

  2005cited by this paper
• Cell surface receptors in lysophospholipid signaling.

  2004cited by this paper
• Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells.

  2004cited by this paper
• The emerging role of lysophosphatidic acid in cancer

  2003cited by this paper
• Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation.

  2002cited by this paper
• Adhesive mechanisms regulating invasion and metastasis in oral cancer.

  2001cited by this paper
• Stimulation of hepatocyte DNA synthesis by prostaglandin E2 and prostaglandin F2α additivity with the effect of norepinephrine, and synergism with epidermal growth factor

  1994cited by this paper
• Molecular biology of head and neck cancer.

  1994cited by this paper

• Lysophosphatidic acid induces the migration and invasion of SGC-7901 gastric cancer cells through the LPA2 and Notch signaling pathways

  2019cites this paper